UNBSF (Uni-Bio Science Group) Cyclically Adjusted PS Ratio: (As of Aug. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

UNBSF Uni-Bio Science Group Ltd UNBSF
58 GF Score
Price $0.00
GF Value $0.01
! 3 Warning Signs
View Full Analysis

What is Uni-Bio Science Group Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Uni-Bio Science Group  (OTCPK:UNBSF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Uni-Bio Science Group Cyclically Adjusted PS Ratio Related Terms


Uni-Bio Science Group Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Uni-Bio Science Group's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Uni-Bio Science Group Cyclically Adjusted PS Ratio Chart

Uni-Bio Science Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.06 1.68 1.66 1.23 2.08

Uni-Bio Science Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.66 0.00 1.23 0.00 2.08

UNBSF vs VRTX, REGN, RVMD: Cyclically Adjusted PS Ratio Comparison

For the Biotechnology subindustry, Uni-Bio Science Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Uni-Bio Science Group Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Uni-Bio Science Group's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Uni-Bio Science Group's Cyclically Adjusted PS Ratio falls into.


UNBSF
58GF Score
Uni-Bio Science Group Ltd UNBSF
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Uni-Bio Science Group Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Uni-Bio Science Group's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec25 is calculated as:

For example, Uni-Bio Science Group's adjusted Revenue per Share data for the fiscal year that ended in Dec25 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec25 (Change)*Current CPI (Dec25)
=0.013/120.7036*120.7036
=0.013

Current CPI (Dec25) = 120.7036.

Uni-Bio Science Group Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201612 0.004 103.225 0.005
201712 0.004 104.984 0.005
201812 0.003 107.622 0.003
201912 0.004 110.700 0.004
202012 0.004 109.711 0.004
202112 0.007 112.349 0.008
202212 0.009 114.548 0.009
202312 0.010 117.296 0.010
202412 0.012 118.945 0.012
202512 0.013 120.704 0.013

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Uni-Bio Science Group (UNBSF) Overvalued in 2026?

Based on GuruFocus' analysis, Uni-Bio Science Group stock appears to be undervalued. The current stock price of $0.00 is trading 60% below its estimated GF Value™ of $0.01.

Key valuation signals for UNBSF:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: $0.01 vs. price of $0.00 (60% below fair value)
  • GF Score™: 58/100 with 3 warning signs

No single metric tells the full story. See the UNBSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Uni-Bio Science Group Business Description

Other Exchanges 00690:Hong Kong
Address No. 20 Science Park East Avenue, Unit 502, 5th Floor, Hong Kong Science Park, Shatin, New Territories, Hong Kong, HKG
Uni-Bio Science Group Ltd is an investment holding company. It operates in three segments: Chemical pharmaceutical products, Biological pharmaceutical products, and Pipeline products. Its geographical segments are Hong Kong and China, of which all of its revenue comes from China. The company products include GeneSoft, GeneTime, Pinup, Boshutai, Bokangtai, and others. All of the company revenue is generated from PRC.
58GF Score

Get the complete analysis for UNBSF

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price
$0.01
GF Value